(Q68833154)
Statements
In vivo and in vitro activation of natural killer cells in advanced cancer patients undergoing combined recombinant interleukin-2 and LAK cell therapy (English)
J H Phillips
B T Gemlo
W W Myers
A A Rayner
1 December 1987